Author:
He Nana,Zhang Yuelin,Zhang Shun,Wang Dongjuan,Ye Honghua
Funder
Ningbo Health Branding Subject Fund
Ningbo medical science and technology project
Ningbo HwaMei research fund
Zhejiang Province Public Welfare Technology Application Research Project
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference94 articles.
1. Silvestre, J. S. (2016). Stem cell therapy for cardiovascular diseases. Artery Research, 16, 45–45.
2. Terashvili, M., & Bosnjak, Z. J. (2019). Stem cell therapies in cardiovascular disease. Journal of Cardiothoracic and Vascular Anesthesia, 33(1), 209–222.
3. Bagno, L., Hatzistergos, K. E., Balkan, W., & Hare, J. M. (2018). Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Molecular Therapy, 26(7), 1610–1623.
4. Khan, M., Nickoloff, E., Abramova, T., Johnson, J., Verma, S. K., Krishnamurthy, P., & Ramirez, V. (2015). Embryonic stem cell–derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circulation Research, 117(1), 52–64.
5. Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., & Wu, J. C. (2018). Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the American Heart Association. Circulation: Genomic and Precision Medicine, 11(1), e000043.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献